RECRUITING

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19

Talk to us

Conditions

Coronavirus InfectionCOVID-19 symptomsChinese Herbal MedicineCoughShortness of BreathFatigueEpidemicInfectious DiseaseDyspneaDiarrheaMyalgiaNauseaFeverPneumonia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.

Official Title

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19: A Descriptive, Longitudinal, Pragmatic Cohort Study

Quick Facts

Study Start:2020-05-11
Study Completion:2025-05-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04380870

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 114 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Eighteen year of age.
  2. * Experienced one or more of the following symptoms in the last 28 days: cough, fever, shortness of breath, diarrhea, nausea, or abdominal pain OR am at high risk of exposure.
  3. * Have a Primary Care Provider.
  1. * Breastfeeding, pregnant, or expect that I might be pregnant.
  2. * Ineligible to receive a telehealth consult for any reason.
  3. * Unable to communicate in English verbally, and in writing.
  4. * Have an open legal case about my health.
  5. * Taking anticoagulants, immunosuppressants, antiseizure medications, antipsychotic medications or am in active cancer treatment
  6. * Taking medications with some risk of interaction with the herbal medicine. This will be determined at the time of the herbal consult by the clinic team.
  7. * Discretion of the practitioner or screener.

Contacts and Locations

Study Contact

Lisa A Taylor-Swanson, PhD
CONTACT
801-585-5486
lisa.taylor-swanson@nurs.utah.edu
Lisa Conboy, DSc
CONTACT
617-718-1917
lisaconboy@gmail.com

Principal Investigator

Lisa Taylor-Swanson, PhD
PRINCIPAL_INVESTIGATOR
University of Utah
Lisa Conboy, DSc
PRINCIPAL_INVESTIGATOR
Beth Israel Deaconness Medical Center, Harvard Medical School

Study Locations (Sites)

Seattle Intstitute of East Asian Medicine
Seattle, Washington, 98108
United States

Collaborators and Investigators

Sponsor: Center for Integrated Care

  • Lisa Taylor-Swanson, PhD, PRINCIPAL_INVESTIGATOR, University of Utah
  • Lisa Conboy, DSc, PRINCIPAL_INVESTIGATOR, Beth Israel Deaconness Medical Center, Harvard Medical School

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-05-11
Study Completion Date2025-05-11

Study Record Updates

Study Start Date2020-05-11
Study Completion Date2025-05-11

Terms related to this study

Keywords Provided by Researchers

  • COVID-19 symptoms
  • Chinese Herbal Medicine
  • Cough
  • Shortness of Breath
  • Fatigue
  • Epidemic
  • Infectious Disease
  • Dyspnea
  • Diarrhea
  • Myalgia
  • Nausea
  • Fever
  • Pneumonia

Additional Relevant MeSH Terms

  • Coronavirus Infection